Skip to main content
. Author manuscript; available in PMC: 2007 Feb 13.
Published in final edited form as: Nat Immunol. 2006 Oct 1;7(11):1209–1216. doi: 10.1038/ni1392

Figure 6.

Figure 6

Apoptotic activated peripheral blood T cells have high expression of CCR5. (a) Flow cytometry of the surface phenotype of peripheral blood T cells activated for 3 d by anti-CD3 (5 μg/ml). Gray bar, percent death of all cells. (b,c) Flow cytometry of CCR5 surface expression (b) and apoptotic surface phenotype (c) of T cells activated as described in a and treated for 4–48 h with staurosporine (STS). *, P < 0.05, versus late apoptotic. Results are representative of three experiments.